Achieving Cardiovascular Health Equity in Community Mental Health: Optimizing Implementation Strategies
Launched by JOHNS HOPKINS UNIVERSITY · Nov 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve heart health for people with serious mental illnesses, like depression or schizophrenia. The researchers are focusing on a program called IDEAL Goals, which is designed to help reduce the risk of heart disease. They want to see how well this program is adopted by community mental health programs in Michigan and Maryland, and they will try different approaches to make it work better for those who need it.
If you're part of a community mental health program and are 18 years or older, speak English, and are willing to help with the study, you may be eligible to participate. As a participant, you can expect to engage with the IDEAL Goals program based on your role, such as receiving training or helping deliver the program. This trial aims to make heart health resources more accessible for people facing serious mental health challenges, ultimately helping them live healthier lives.
Gender
ALL
Eligibility criteria
- Community Mental Health Program site staff participants:
- • Inclusion Criteria
- • 1. Ages 18 and Older
- • 2. English Speaking
- • 3. Agree to complete applicable data collection
- • 4. Agree to engage with the program according to their role (e.g., training, IDEAL Goals program delivery).
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Gail Daumit, MD, MHS
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported